Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Weeks 9-12 : The dosage is raised to 1.0 mg weekly
Retatrutide, also identified by the development code LY3437943, is a single-molecule triple receptor agonist studied for its simultaneous activity at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
10.1016/j.chroma.2008.08.023 118 MiyasakaS
Free Radic Biol Med 33:311322 Buffinton GD, Doe WF (1995) Depleted mucosal antioxidant defences in inflammatory bowel disease
US$ 20.88
US$ 28.92
US$ 22.24
US$ 27.58
US$ 29.53
US$ 27.11
US$ 26.77
US$ 26.17
